HOOKIPA PHARMA INC's ticker is HOOK and the CUSIP is 43906K100. A total of 73 filers reported holding HOOKIPA PHARMA INC in Q2 2021. The put-call ratio across all filers is 8.94 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $181,868 | -19.7% | 295,240 | +14.7% | 0.00% | – |
Q2 2023 | $226,528 | -9.1% | 257,418 | -24.0% | 0.00% | – |
Q1 2023 | $249,264 | -8.2% | 338,674 | +1.1% | 0.00% | – |
Q4 2022 | $271,421 | -39.0% | 335,087 | +0.7% | 0.00% | – |
Q3 2022 | $445,000 | -17.1% | 332,784 | +1.2% | 0.00% | – |
Q2 2022 | $537,000 | -79.7% | 328,799 | -71.6% | 0.00% | – |
Q1 2022 | $2,642,000 | -6.5% | 1,159,172 | -4.4% | 0.00% | – |
Q4 2021 | $2,825,000 | -54.5% | 1,212,502 | +15.1% | 0.00% | – |
Q3 2021 | $6,204,000 | -35.5% | 1,053,514 | +0.3% | 0.00% | – |
Q2 2021 | $9,624,000 | -3.8% | 1,050,521 | +41.2% | 0.00% | – |
Q1 2021 | $10,005,000 | +40.3% | 743,787 | +15.7% | 0.00% | – |
Q4 2020 | $7,130,000 | +20.5% | 642,829 | +2.9% | 0.00% | – |
Q3 2020 | $5,916,000 | -13.6% | 624,769 | +6.0% | 0.00% | – |
Q2 2020 | $6,849,000 | +79.7% | 589,454 | +27.5% | 0.00% | – |
Q1 2020 | $3,812,000 | -24.4% | 462,185 | +12.1% | 0.00% | – |
Q4 2019 | $5,042,000 | +457.1% | 412,256 | +241.5% | 0.00% | – |
Q3 2019 | $905,000 | +22.8% | 120,734 | +10.2% | 0.00% | – |
Q2 2019 | $737,000 | – | 109,528 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Redmile Group, LLC | 1,842,902 | $17,452,000 | 0.32% |
Samsara BioCapital, LLC | 116,602 | $1,104,000 | 0.31% |
Artal Group S.A. | 599,616 | $5,678,000 | 0.14% |
HHLR ADVISORS, LTD. | 943,254 | $8,933,000 | 0.07% |
DAFNA Capital Management LLC | 22,061 | $209,000 | 0.07% |
Baker Brothers Advisors | 700,481 | $6,634,000 | 0.03% |
ZACKS INVESTMENT MANAGEMENT | 72,064 | $682,000 | 0.01% |
HOWLAND CAPITAL MANAGEMENT LLC | 14,728 | $139,000 | 0.01% |
ETF MANAGERS GROUP, LLC | 14,374 | $139,000 | 0.00% |
Squarepoint Ops LLC | 12,699 | $120,000 | 0.00% |